Colleen Susanne Delaney MD
Assistant Professor of Pediatrics, University Wash
Join to view full profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-288-1000
Dr. Delaney is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 1999 - 2002
University of California (San Francisco)Residency, Pediatrics, 1996 - 1999
Harvard Medical SchoolClass of 1996
Certifications & Licensure
CA State Medical License 1998 - Present
WA State Medical License 2001 - 2028
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies
- Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease Start of enrollment: 2005 Nov 18
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 2008 Jun 25
Publications & Presentations
PubMed
- 2 citationsSafety and Clinical Outcomes of Pooled Donor, Nonengrafting Expanded Progenitor Cells in Single-Unit Cord Blood Transplantation.Filippo Milano, Ann Dahlberg, Jenna Pedersen, Laura Roberts, Alessandra Azure
Journal of Clinical Oncology. 2026-07-20 - 3 citationsLong-term outcomes and quality of life with treosulfan-based conditioning in hematological malignancies.Rohtesh S Mehta, Stephanie J Lee, Ted Gooley, Laurel Thur, Ann Dahlberg
Blood Advances. 2025-06-10 - Differentiation latency, cell division symmetry, and dormancy signatures define fetal liver HSCs at single cell resolution.Takashi Ishida, Juliane Mercoli, Adam M Heck, Ian Phelps, Barbara Varnum-Finney
Biorxiv. 2025-05-02
Journal Articles
- Disability Related to Chronic Graft-Versus-Host Disease After Alternative Donor Hematopoietic Cell TransplantationMary E Flowers, Brenda M Sandmaier, Rachel B Salit, Colleen Delaney, Filippo Milano, Stephanie J Lee, Haematologica
Abstracts/Posters
- Cord Blood Transplantation Is an Effective Treatment Option in Patients with Myelodysplastic and Myeloproliferative SyndromesColleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Comparison of Outcomes between HSCT Donor Sources for Pediatric Patients with Hematologic MalignanciesColleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral ProphylaxisColleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Nohla Therapeutics Announces Hiring of Dr. Sarah Noonberg as Chief Medical Officer and Appointment of Dr. Colleen Delaney as Chief Scientific OfficerJuly 30th, 2018
Fred Hutch Tip Sheet: Breast Cancer, Skin Cells as a Cancer Repair Mechanism, HIV Prevention Study, Air Pollution Risk and MoreAugust 24th, 2017
Kleberg Foundation Grant to Support Clinical Trial for Leukemia PatientsAugust 17th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: